Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

mRNA Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients

NCT00929019 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT00929019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00929019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
mRNA Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients
Lead sponsor
Radboud University Medical Center
Phase
Phase 1/2
Overall status
Terminated
Start date
June 30, 2009
Completion date
April 30, 2016
Enrollment
23 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

uveal melanoma